Evidence Hub

624. The influence of psychiatric comorbidity on the level of adherence to psychopharmacotherapy in patients with bipolar disorder

S. Vasilieva, G. Simutkin, N. Bokhan

International Journal of Neuropsychopharmacology, 2026

60 participants

Abstract

Abstract Background The most promising way to improve public health is a strategy to increase adherence to treatment, even compared to efforts to create and develop new effective treatments [1]. Patients with bipolar disorder (BD) often have low levels of adherence to treatment, which has been demonstrated in numerous studies using various assessment methods [2, 3, 4, 5, 6, 7]. Aims & Objectives To identify influence of psychiatric comorbidity on the level of adherence to psychopharmacotherapy in patients with bipolar disorder. Method 106 inpatients diagnosed with BD were examined. Inclusion criteria were: diagnosis of BD according to ICD-10 criteria; previously prescribed pharmacotherapy for BD; age from 18 to 65 years; patient consent to participate in the study and patient’s compliance with therapy. Exclusion criteria: primary patient seeking psychiatric care; pregnancy; dementia; schizophrenia. Evaluation of adherence to therapy was comprehensive: clinical interviews; anamnestic data from people who knew the patient well; determination of the concentration of normothymic medication in the blood. In the study group, women constituted 56.6% (n=60), men 43.4% (n=46). The median age of male patients was 34 [29; 41] years, and of female patients was 32 [25; 48] years. Results In the study group, 59 patients (55.7%) had another mental disorder in addition to BD: alcohol dependence, anxiety spectrum disorders, personality disorder. An assessment of the level of adherence taking…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free